Skip to main content
Onaopepo Kola-Kehinde, MD, Internal Medicine, Memphis, TN

Onaopepo Kola-Kehinde MD


Physician

Join to View Full Profile
  • 1265 Union AveMemphis, TN 38104

  • Phone+1 901-516-8279

Dr. Kola-Kehinde is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Onaopepo Kola-Kehinde, MD has contributed to several publications, notably in fields related to cardiotoxicity and cancer therapy, such as "Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia" and others, with varying citation counts. His academic honors include the Medical Student Pelotonia Scholars Program and membership in the Landacre Research Honor Society and Gold Humanism Honor Society at Ohio State University.

Education & Training

  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 2025

Awards, Honors, & Recognition

  • Medical Student Pelotonia Scholars Program The Ohio State University Comprehensive Cancer Center, 2022-2023
  • Landacre Research Honor Society The Ohio state University College of Medicine, 2022

Publications & Presentations

PubMed

Abstracts/Posters

  • Myocardial Injury after Ibrutinib Initiation for Hematologic Malignancies
    Buck, B., Chum, A.P., Kola-Kehinde, O., Patel, M., Carter, R., Nawaz, H., Yildiz, V., Ruz, P., Wiczer, T., Rogers, K.A., Awan, F.T., Bhat, S., Guha, A., Kittai, A.S., ..., American College of Cardiology Annual Scientific Session
  • Preoperative risk assessment for early stroke following thoracic endovascular aortic aneurysm repair
    Kola-Kehinde O, Mpody C, Elsayed-Awad H, Bhandary S.P, Essandoh M, Tobias J, Olubukola N., 2021 American Society of Anesthesiologists Annual Meeting, San Diego, CA, 10/18/2021
  • Cardiotoxic safety communications after FDA approval of novel cancer therapies.
    Bonsu J, Kola-Kehinde O, Kim L, Ruz P, Lustberg M.B, Brammer J.E, Addison D, Journal of Clinical Oncology, 2021
  • Join now to see all

Professional Memberships

  • American College of Cardiology
    Member

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: